U.S., March 28 -- ClinicalTrials.gov registry received information related to the study (NCT07497607) titled 'Reduced Elective Nodal and CTV Dose for HPV+ Oropharyngeal Squamous Cell Carcinoma' on Mar... Read More
U.S., March 28 -- ClinicalTrials.gov registry received information related to the study (NCT07498062) titled 'Multimodal Chewing Gum Flavour Training to Aid Flavour Perception Recovery - a Pilot Study... Read More
U.S., March 28 -- ClinicalTrials.gov registry received information related to the study (NCT07494396) titled 'An AI-Based Erythema Measurement System for Psoriasis Lesions' on March 20. Brief Summary... Read More
U.S., March 28 -- ClinicalTrials.gov registry received information related to the study (NCT07496229) titled 'Assessing Treatment of T-Cell Lymphoma With GW5282 in Combination With Golidocitinib (BEI-... Read More
U.S., March 28 -- ClinicalTrials.gov registry received information related to the study (NCT07497061) titled 'Randomized Clinical Trial Comparing Two Surgical Techniques for the Treatment of Trigger F... Read More
U.S., March 28 -- ClinicalTrials.gov registry received information related to the study (NCT07497919) titled 'A Study of Becotatug Vedotin Combined With Pucotenlimab in the Treatment of EGFR-Positive ... Read More
U.S., March 28 -- ClinicalTrials.gov registry received information related to the study (NCT07497698) titled 'Saffron Extract Supplementation and Sleep Quality in Middle-Aged Adults' on March 23. Bri... Read More
U.S., March 28 -- ClinicalTrials.gov registry received information related to the study (NCT07496294) titled 'Comparison of Oral Dydrogesterone and Vaginal Progesterone in Menopausal Hormone Therapy' ... Read More
U.S., March 28 -- ClinicalTrials.gov registry received information related to the study (NCT07498231) titled 'COronoary Microcirculation Analysis NETwork' on March 23. Brief Summary: COMA.NET (COrona... Read More
U.S., March 28 -- ClinicalTrials.gov registry received information related to the study (NCT07498465) titled 'A Study to Find the Highest Dose of SNDX-5613 (Revumenib) as a Treatment Option After Hema... Read More